| |
| | Lexicon Genetics Announces Rapid New Method for Accelerating Drug Discovery (Site not responding. Last check: 2007-10-20) |
 | | THE WOODLANDS, Texas, June 24/PRNewswire/NEWSdesk/ -- Lexicon Genetics Incorporated announced today the development of a powerful new approach in understanding the function of newly discovered human genes and in validating potential drug targets using Lambda KOS, the Company's proprietary gene targeting and gene replacement system. |
 | | Lexicon's Lambda KOS system has already been used to mutate gene targets and expedite the drug discovery process through the creation of knockout mice in agreements with Merck and Co., Inc., ZymoGenetics, Inc., Genetics Institute, Cephalon, H. Lundbeck A/S, The Rockefeller University, Tufts University, University of Rochester and many others. |
 | | Lexicon Genetics Incorporated (http://www.lexgen.com/) is a pioneer in the design and development of high-throughput mutagenesis technologies for studying functional genomics in mammalian systems. |
| www.findwealth.com /lexicon-genetics-announces-rapid-new-61633pr.html (731 words) |
|